Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Secotex ®: Prescription Event Monitoring in Patients With Benign Prostatic Hyperplasia (BPH)

NCT02245529 is registered in ClinicalTrials.gov with Boehringer Ingelheim as lead sponsor.

NCT NCT02245529
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02245529 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Secotex ®: Prescription Event Monitoring in Patients With Benign Prostatic Hyperplasia (BPH)
Lead sponsor
Boehringer Ingelheim
Phase
Observational
Overall status
Completed
Start date
March 31, 2005
Completion date
Not reported
Enrollment
982 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

prostatic hyperplasia